The in vitro effect of hyaluronic acid on IL-1β production in cultured rheumatoid synovial cells

Sawako Takeshita, Syoji Mizuno, Toshiyuki Kikuchi, Harumoto Yamada, Osamu Namiki, Katsuo Kumagai

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Hyaluronic acid (HA) is a multifunctional glycosaminoglycan. In this study, we examined the in vitro effect of HA on interleukin-1β (IL-1β) production in cultured rheumatoid synovial cells from 19 joints. We also examined the interactions between HA and CD44 on the cells from 11 joints by flow cytometric analysis. HA (0.3, 1 and 3 mg/ml) inhibited IL-1β production with phorbol 12-myristate 13-acetate (PMA) stimulation in a dose-dependent manner, and the percentage relative to the control was respectively 80 ± 5, 66 ± 5, and 48 ± 3% (P < 0.05). OS/37, an anti-CD44 monoclonal antibody, is known to block the interaction between HA and CD44. Flow cytometric analysis demonstrated that OS/37 blocked fluoresceinamine-conjugated hyaluronic acid (FAHA) binding to rheumatoid arthritis synovial cells, but the percentage of inhibition varied depending on the individuals, yielding an average of inhibition as low as 22% in 11 test specimens. This result suggested that HA exhibited a binding affinity for CD44, but the binding of HA to CD44 occurred in a minor population of synovial cells. After treatment of the cells with chondroitinase, FAHA binding significantly increased (from 28% to 58%), and the blocking of FAHA binding by OS/37 was also markedly increased (from 22% to 71%). Additionally, there was a good correlation between the mean fluorescence of FITC-OS/37 staining and FAHA staining of synovial cells treated with chondroitinase, suggesting that HA binds to CD44 specifically in the major population of synovial cells treated with chondroitinase. Moreover, HA more efficiently reduced IL-1β production in the cell treated with chondroitinase compared with that in the non-treated cells. The results suggest the possibility that the treatment of the cells with chondroitinase modified the surface molecules including CD44 to increase their binding affinity for CD44, resulting in enhancement of HA-induced suppression of IL-1β production. In conclusion, HA may directly reduce IL-1β production by rheumatoid synovial cells and regulate it via CD44.

Original languageEnglish
Pages (from-to)187-194
Number of pages8
JournalBiomedical Research
Volume18
Issue number3
Publication statusPublished - 01-06-1997

Fingerprint

Hyaluronic Acid
Interleukin-1
Chondroitinases and Chondroitin Lyases
Cells
In Vitro Techniques
Joints
Staining and Labeling
Fluorescein-5-isothiocyanate
Glycosaminoglycans
Population
Rheumatoid Arthritis
Acetates

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Takeshita, S., Mizuno, S., Kikuchi, T., Yamada, H., Namiki, O., & Kumagai, K. (1997). The in vitro effect of hyaluronic acid on IL-1β production in cultured rheumatoid synovial cells. Biomedical Research, 18(3), 187-194.
Takeshita, Sawako ; Mizuno, Syoji ; Kikuchi, Toshiyuki ; Yamada, Harumoto ; Namiki, Osamu ; Kumagai, Katsuo. / The in vitro effect of hyaluronic acid on IL-1β production in cultured rheumatoid synovial cells. In: Biomedical Research. 1997 ; Vol. 18, No. 3. pp. 187-194.
@article{d14547f46b0444dcb269484205ba7fba,
title = "The in vitro effect of hyaluronic acid on IL-1β production in cultured rheumatoid synovial cells",
abstract = "Hyaluronic acid (HA) is a multifunctional glycosaminoglycan. In this study, we examined the in vitro effect of HA on interleukin-1β (IL-1β) production in cultured rheumatoid synovial cells from 19 joints. We also examined the interactions between HA and CD44 on the cells from 11 joints by flow cytometric analysis. HA (0.3, 1 and 3 mg/ml) inhibited IL-1β production with phorbol 12-myristate 13-acetate (PMA) stimulation in a dose-dependent manner, and the percentage relative to the control was respectively 80 ± 5, 66 ± 5, and 48 ± 3{\%} (P < 0.05). OS/37, an anti-CD44 monoclonal antibody, is known to block the interaction between HA and CD44. Flow cytometric analysis demonstrated that OS/37 blocked fluoresceinamine-conjugated hyaluronic acid (FAHA) binding to rheumatoid arthritis synovial cells, but the percentage of inhibition varied depending on the individuals, yielding an average of inhibition as low as 22{\%} in 11 test specimens. This result suggested that HA exhibited a binding affinity for CD44, but the binding of HA to CD44 occurred in a minor population of synovial cells. After treatment of the cells with chondroitinase, FAHA binding significantly increased (from 28{\%} to 58{\%}), and the blocking of FAHA binding by OS/37 was also markedly increased (from 22{\%} to 71{\%}). Additionally, there was a good correlation between the mean fluorescence of FITC-OS/37 staining and FAHA staining of synovial cells treated with chondroitinase, suggesting that HA binds to CD44 specifically in the major population of synovial cells treated with chondroitinase. Moreover, HA more efficiently reduced IL-1β production in the cell treated with chondroitinase compared with that in the non-treated cells. The results suggest the possibility that the treatment of the cells with chondroitinase modified the surface molecules including CD44 to increase their binding affinity for CD44, resulting in enhancement of HA-induced suppression of IL-1β production. In conclusion, HA may directly reduce IL-1β production by rheumatoid synovial cells and regulate it via CD44.",
author = "Sawako Takeshita and Syoji Mizuno and Toshiyuki Kikuchi and Harumoto Yamada and Osamu Namiki and Katsuo Kumagai",
year = "1997",
month = "6",
day = "1",
language = "English",
volume = "18",
pages = "187--194",
journal = "Biomedical Research",
issn = "0388-6107",
publisher = "Biomedical Research Foundation",
number = "3",

}

Takeshita, S, Mizuno, S, Kikuchi, T, Yamada, H, Namiki, O & Kumagai, K 1997, 'The in vitro effect of hyaluronic acid on IL-1β production in cultured rheumatoid synovial cells', Biomedical Research, vol. 18, no. 3, pp. 187-194.

The in vitro effect of hyaluronic acid on IL-1β production in cultured rheumatoid synovial cells. / Takeshita, Sawako; Mizuno, Syoji; Kikuchi, Toshiyuki; Yamada, Harumoto; Namiki, Osamu; Kumagai, Katsuo.

In: Biomedical Research, Vol. 18, No. 3, 01.06.1997, p. 187-194.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The in vitro effect of hyaluronic acid on IL-1β production in cultured rheumatoid synovial cells

AU - Takeshita, Sawako

AU - Mizuno, Syoji

AU - Kikuchi, Toshiyuki

AU - Yamada, Harumoto

AU - Namiki, Osamu

AU - Kumagai, Katsuo

PY - 1997/6/1

Y1 - 1997/6/1

N2 - Hyaluronic acid (HA) is a multifunctional glycosaminoglycan. In this study, we examined the in vitro effect of HA on interleukin-1β (IL-1β) production in cultured rheumatoid synovial cells from 19 joints. We also examined the interactions between HA and CD44 on the cells from 11 joints by flow cytometric analysis. HA (0.3, 1 and 3 mg/ml) inhibited IL-1β production with phorbol 12-myristate 13-acetate (PMA) stimulation in a dose-dependent manner, and the percentage relative to the control was respectively 80 ± 5, 66 ± 5, and 48 ± 3% (P < 0.05). OS/37, an anti-CD44 monoclonal antibody, is known to block the interaction between HA and CD44. Flow cytometric analysis demonstrated that OS/37 blocked fluoresceinamine-conjugated hyaluronic acid (FAHA) binding to rheumatoid arthritis synovial cells, but the percentage of inhibition varied depending on the individuals, yielding an average of inhibition as low as 22% in 11 test specimens. This result suggested that HA exhibited a binding affinity for CD44, but the binding of HA to CD44 occurred in a minor population of synovial cells. After treatment of the cells with chondroitinase, FAHA binding significantly increased (from 28% to 58%), and the blocking of FAHA binding by OS/37 was also markedly increased (from 22% to 71%). Additionally, there was a good correlation between the mean fluorescence of FITC-OS/37 staining and FAHA staining of synovial cells treated with chondroitinase, suggesting that HA binds to CD44 specifically in the major population of synovial cells treated with chondroitinase. Moreover, HA more efficiently reduced IL-1β production in the cell treated with chondroitinase compared with that in the non-treated cells. The results suggest the possibility that the treatment of the cells with chondroitinase modified the surface molecules including CD44 to increase their binding affinity for CD44, resulting in enhancement of HA-induced suppression of IL-1β production. In conclusion, HA may directly reduce IL-1β production by rheumatoid synovial cells and regulate it via CD44.

AB - Hyaluronic acid (HA) is a multifunctional glycosaminoglycan. In this study, we examined the in vitro effect of HA on interleukin-1β (IL-1β) production in cultured rheumatoid synovial cells from 19 joints. We also examined the interactions between HA and CD44 on the cells from 11 joints by flow cytometric analysis. HA (0.3, 1 and 3 mg/ml) inhibited IL-1β production with phorbol 12-myristate 13-acetate (PMA) stimulation in a dose-dependent manner, and the percentage relative to the control was respectively 80 ± 5, 66 ± 5, and 48 ± 3% (P < 0.05). OS/37, an anti-CD44 monoclonal antibody, is known to block the interaction between HA and CD44. Flow cytometric analysis demonstrated that OS/37 blocked fluoresceinamine-conjugated hyaluronic acid (FAHA) binding to rheumatoid arthritis synovial cells, but the percentage of inhibition varied depending on the individuals, yielding an average of inhibition as low as 22% in 11 test specimens. This result suggested that HA exhibited a binding affinity for CD44, but the binding of HA to CD44 occurred in a minor population of synovial cells. After treatment of the cells with chondroitinase, FAHA binding significantly increased (from 28% to 58%), and the blocking of FAHA binding by OS/37 was also markedly increased (from 22% to 71%). Additionally, there was a good correlation between the mean fluorescence of FITC-OS/37 staining and FAHA staining of synovial cells treated with chondroitinase, suggesting that HA binds to CD44 specifically in the major population of synovial cells treated with chondroitinase. Moreover, HA more efficiently reduced IL-1β production in the cell treated with chondroitinase compared with that in the non-treated cells. The results suggest the possibility that the treatment of the cells with chondroitinase modified the surface molecules including CD44 to increase their binding affinity for CD44, resulting in enhancement of HA-induced suppression of IL-1β production. In conclusion, HA may directly reduce IL-1β production by rheumatoid synovial cells and regulate it via CD44.

UR - http://www.scopus.com/inward/record.url?scp=0030845888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030845888&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030845888

VL - 18

SP - 187

EP - 194

JO - Biomedical Research

JF - Biomedical Research

SN - 0388-6107

IS - 3

ER -

Takeshita S, Mizuno S, Kikuchi T, Yamada H, Namiki O, Kumagai K. The in vitro effect of hyaluronic acid on IL-1β production in cultured rheumatoid synovial cells. Biomedical Research. 1997 Jun 1;18(3):187-194.